Table 4.
Number of site-specific cancer and comparison between different eGFR groups
| Site-specific cancer | Total number | Number of cancer according to eGFR (ml/min/1.73m2) | P | ||
|---|---|---|---|---|---|
| eGFR ≥ 90 | eGFR 60 to 89 | eGFR < 60 | |||
| brain | 5 | 4 | 1 | 0 | 0.72 |
| Oral cavity | 2 | 1 | 1 | 0 | 1.00 |
| Larynx | 7 | 5 | 1 | 1 | 0.23 |
| Other pharynx | 5 | 3 | 1 | 1 | 0.20 |
| Thyroid | 7 | 6 | 1 | 0 | 0.56 |
| Lung | 43 | 21 | 15 | 7 | 0.001 |
| Breast | 12 | 9 | 3 | 0 | 0.71 |
| Esophagus | 24 | 14 | 10 | 0 | 0.61 |
| Stomach | 19 | 12 | 6 | 1 | 0.66 |
| Liver | 33 | 14 | 16 | 3 | 0.02 |
| Pancreas | 7 | 4 | 3 | 0 | 0.76 |
| Kidney | 4 | 1 | 1 | 2 | 0.007 |
| Prostate | 3 | 2 | 0 | 1 | 0.09 |
| Testicle | 0 | 0 | 0 | 0 | - |
| Ovary | 4 | 4 | 0 | 0 | 0.40 |
| Cervix | 14 | 11 | 3 | 0 | 0.63 |
| Endometrium | 17 | 15 | 2 | 0 | 0.13 |
| Colon or rectum | 16 | 5 | 8 | 3 | 0.004 |
| Bladder | 4 | 1 | 2 | 1 | 0.05 |
| Skin | 4 | 1 | 2 | 1 | 0.05 |
| Non-Hodgkin lymphoma | 4 | 3 | 1 | 0 | 1.00 |
| Leukemia | 0 | 0 | 0 | 0 | - |
| Other location | 35 | 14 | 15 | 6 | 0.001 |
Note: Fisher's exact tests were used due to the expected frequency <1.